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Working under the influence of drugs and/or alcohol may affect safety and job performance. However, the size of
this possible problem among health professionals (HPs) is unknown. The aim of this study was threefold: (i) to
analyze samples of oral fluid and self-reported data from questionnaires to investigate the prevalence of alcohol
and drugs among a sample of HPs in Norway, (ii) to study self-reported absence from or impairment at work due
to alcohol and/or drug use, and (iii) to examine whether such use and absence/impairment due to such use
depend on socio-demographic variables.
A total of 916 of the 933 invited HPs from hospitals and pharmacies participated in the study (participation rate = 98.2%),
and 81.1% were women. Associations were analyzed in bi-variate cross tables with Chi-square statistics to assess statistical
significance.
Alcohol was not detected in any of the samples. Ethyl glucuronide, a specific alcohol metabolite, was found in 0.3% of
the collected samples. Illicit drugs and medicinal drugs were identified in 0.6% and 7.3% of the samples, respectively.
Both analytical results and self-reported use of alcohol and drugs during the past 12 months indicate that recent and
past year alcohol and drug use was lower among HPs than among workers in other business areas in Norway, Europe
and US. Nevertheless, several HPs reported absence from work due to alcohol (0.9%) and medicinal drug use (0.8%)
during the past 12 months. A substantial part (16.7%) of the self-reported medicinal drug users reported absence from
work because of use of medicinal drugs during the past 12 months, and more than 1/4 of those reported in-efficiency
at work because of the use of medicinal drugs during the past 12 months. Reduced efficiency at work due to alcohol
use during the past 12 months was reported by 12.2%.
This sample of HPs seldom used illicit drugs, few had a high level of alcohol consumption, and few tested positive for
medicinal drugs. Absence or hangover related to the use of medicinal drugs or alcohol appeared to be a bigger issue
than the acute intoxication or the use of illicit drugs.
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Alcohol and drug use may both have acute and long
term consequences for the workplace. It is well known
that such use and/or hangover effects may cause an
increased risk for accidents, faults, inefficiency, and
absence from work [1-4], all undesired effects.
Health professionals (HPs) are employees that have
easy access to medicines at work, and the consequences
of abuse may affect both themselves and patients [5].
The psychoactive effects of drugs may be caused by an
acute pharmacological effect or hangover effect that
influences the performance of the user even though the
active compounds are cleared from the brain. Therefore,
the effects of drugs and alcohol may reduce the effective-
ness at work for many hours after drug intake. In addition,
dependence may cause a sense of craving which may result
in HPs being unfocused at work [5].
The Norwegian Board of Health Supervision withdraws
the authorization from several HPs every year due to im-
pairment by psychoactive compounds at work [6]. The true
extent of HPs being unfit to work due to impairment is not
known, and surveys aimed at estimating the prevalence
have not previously been conducted.
Workplace Drug Testing (WDT) is one method to
investigate the prevalence of drug use among employees.
It is performed by analyzing biological samples, primarily
urine, but other matrices such as oral fluid (OF) and hair
may also be used for that purpose. In Norway, WDT is
not as common as in Sweden or in some other European
countries [7], and it is mainly done within the transport,
petrochemical, shipping, automobile, pharmaceutical and
computer industries, and urine is the matrix of
choice. In the US, workplace testing is more widespread
and also mandatory for many lines of businesses [8,9], the
prevalence of positive urine samples has decreased from
13.6% in 1988 to 3.6% in 2009/2010 [8].
Studies on alcohol and drug use, and the extent of work-
ing under the influence of those types of substances may be
performed by collecting self-reported information in
addition to analysis of biological samples, which provides
information about recent alcohol and drug use. The length
of time the sample will be positive after substance use
depends on type of matrix, taken dose, time between
substance use and sampling, and analytical cut-off
value. In addition, the number of substances in the
panel is important; it should cover the most commonly
used and misused drugs. Specific and sensitive analytical
methods will not detect other compounds than those that
are included in the test panel. A positive finding in OF
typically indicates drug use during the past 24–48 hours
[10]. A negative finding does not prove non-use of a
substance; it merely indicates that the probability of
recent use of the substances in the test panel is very small.
By using questionnaires, one can obtain a wider picture(compared to biological samples taken once) of the
pattern of alcohol and drug use, e.g., how frequently
a person typically drinks during a 12 month period,
how frequently a person drinks to intoxication and/or
experiences amnesia and/or other unpleasant effects
due to alcohol use during the same period. Moreover,
by using questionnaires it is also possible to get more
information about the consequences alcohol and drug
use may have for the workplace, e.g., in terms of sickness
absence, reduced productivity, etc. [4,11]. Finally, this
information can be used to determine the strength of
the relationship between alcohol and drug use and the con-
sequences of such use for the workplace. One drawback
with self-reported data is the risk of under-reporting, but
over-reporting may also occur.
The prevalence of alcohol and drug use among
employees in Norway has received scant research
attention. One previous Norwegian study on alcohol
habits among medical doctors have been conducted
[12]. Postal questionnaires were collected, and the
response rate was 86%. The study revealed that surgeons
(and women in particular) drank more frequently and
more hazardously than other doctors [12]. However, other
HPs were not included and the study did not measure
the extent of the employees being unfit to work due
to impairment. Another previously conducted study
among employees in the private sector in Norway was
also based on questionnaires only to estimate the use
of alcohol and drugs during the past 12 months [13]. A
few other business areas in Norway have been evaluated
in smaller studies [11,14], but WDT with biological
samples among HPs has not yet been undertaken. One
Norwegian pilot study was conducted in 2008–2009,
and analyses of OF and self-reported information were
combined to estimate alcohol and drug use among
Norwegian employees [11]. This study did not include HPs.
From studies conducted in the general population
in Norway, we know that young people have a higher
alcohol consumption and that they more frequently
used illicit drugs than older people, that men both
drink alcohol and use illicit drugs more frequently
than women, whereas medicinal drugs are more frequently
used by older than younger individuals and more often by
women than men [15-17]. Finally, people with a higher
level of education drink more frequently but less alcohol
on each drinking occasion than those with a lower level of
education [15]. Age and gender differences may vary across
different fields of work, e.g. as demonstrated by Rosta and
Aasland [12].
Aims of the study
In light of the different qualities of the two methodological
approaches described above, the first aim of this study was
to estimate alcohol and drug use among a selection of
Edvardsen et al. Journal of Occupational Medicine and Toxicology 2014, 9:8 Page 3 of 10
http://www.occup-med.com/content/9/1/8HPs in Norway using analysis of OF and self-reported data
from questionnaires. OF was chosen for its easy sampling
compared to blood and urine. The participation rate is
higher when collecting OF compared to urine [18]. The
second aim was to study self-reported absence from or
impairment/hangover work due to alcohol or drug use
during the past 12 months. Finally, in light of the
findings from previous studies conducted in the
general population showing that alcohol and drug
use vary significantly according to age, gender and
educational level [15-17], the third aim of this study was
to examine whether the prevalence of alcohol and drug use
among this group of HPs partly depends on these
socio-demographic variables.Methods
The study was performed by using samples of OF and
self-reported data on alcohol and drug use by means
of questionnaires. The study was conducted from
December 2010 to May 2012. A randomized selection of
employees at 3 hospitals and all workers at 4 hospital
pharmacies were asked to participate. The hospital workers
were included if their clinic/department were randomly
selected to participate, and all workers (nurses, medical
doctors, paramedics, secretaries, physiotherapists, cleaning
personnel etc.) at the chosen clinics/departments were
included to provide workers with different background
and educational attainment. The pharmacies provided
pharmacists, pharmacy technicians, secretaries, nurses, etc.
The participants did not receive any remuneration. The
project team members did however actively encourage the
participation. The employers supported the study, and
thorough planning and on-site arrangement was provided.Materials
The participants reported age group, gender, level of educa-
tion, and answered questions about alcohol abstinence
(12 month), recent (24 hour) alcohol use and medicinal
and illicit drug use (48 hours and 12 months), in-efficiency
or hangover at work- and absence from work due to
alcohol or drug use.
Other variables were the presence of alcohol, medicinal
and illicit drugs in samples of OF (see Table 1).Ethics
The dataset was completely anonymous, and the study
was approved by the Regional Committee for Medical
and Health Research Ethics, Norway.Consent
Oral informed consent was obtained from the participants
for publication of reports.Study design and setting
The recruitment of employees was done unannounced
the upcoming quarter after the workers had received
thorough information about the study. Representatives
from the Norwegian Institute of Public Health (NIPH)
visited each workplace and handed out envelopes
containing an information leaflet about the study, a
sampling kit for OF (StatSure Saliva SamplerTM, Statsure
Diagnostic Systems, Framingham, MA) and the question-
naire to each employee that they met the actual day.
Statsure Saliva SamplerTM was chosen because it enabled
the analysis of ethyl glucuronide (EtG) [19] and because
the samples are stable for more than 24 hours before
they need to be frozen after collection [20]. This is
very useful when travelling is necessary for collection.
The participants were given oral and written information
about the study and a detailed instruction on how to
collect OF in the correct manner. Staff from NIPH was
always available to instruct and help the participants. All
the employees had the opportunity to participate and
provide data in privacy, which made the participation
(or no participation) anonymous to colleagues and the
study team. The time used for sample collection and
answering questions was approximately five minutes.
Questionnaires and OF samples were placed in the same,
unlabeled, envelope, which was sealed and collected by
the study team within a few hours. The data collection
was performed during weekdays only.Sample preparation and analysis
The samples of OF were frozen shortly after collection
and thawed once before analysis. All compounds analyzed,
with their lower limit of quantification (LLOQ), are
presented in Table 1.
Alcohol was analyzed by an automated enzymatic
method using alcohol dehydrogenase [21]. EtG was
analyzed using UPLC-MS/MS (Acquity UPLC and
Quattro Premier XE, Waters Corporation, Milford, MA,
USA) with a HSS T3 (1.8 μm 2.1 × 100 mm) column with
a gradient elution of the mobile phase with methanol and
0.1% acetic acid after solid phase extraction (Hyper-SEP
SAX/3 ml/200 mg, Thermo Fisher Scientific Inc., Boston,
MA,USA) [19]. The other compounds (Table 1) were iso-
lated by liquid-liquid extraction using ethyl acetate/heptane
4/1 (v/v) after addition of 0.2 M ammonium carbonate
buffer pH 9.3 and analyzed using UPLC-MS/MS (Acquity
UPLC and Quattro Premier XE, Waters Corporation,
Milford, MA, USA) with a BEH C18 (1.7 μm 2.1 × 50 mm)
column with a gradient elution of the mobile phase with
methanol and 5 mM ammonium bicarbonate buffer pH 8.5
[22]. Concentrations in neat OF were calculated assuming
that 1 mL OF was collected and diluted with 1 mL buffer
in the sampling device.
Table 1 The analytes and their LLOQ values, with prevalence in per cent of all tests and in per cent of all positive
tests (n = 907)
Compound Description LLOQ valued
(ng/mL)
Prevalence of all
tests (%)
Prevalence of all
positive tests (%)
6-Acetylmorphine (6-AM) Metabolite of heroin 0.46 0 0
Alcohol 0.060 g/L 0 0
Alprazolam Benzodiazepinee; anxiolytic 0.19 0 0
7-Aminoclonazepam (7-AC) Metabolite of clonazepame 0.17 0 0
7-Aminoflunitrazepam (7-AF) Metabolite of flunitrazepame 0.060 0 0
7-Aminonitrazepam (7-AN) Metabolite of nitrazepame 0.15 0 0
Amphetamine Stimulantc 1.5 0 0
Benzoylecgonine Metabolite of cocaine 3.3 0.11 1.4
Buprenorphine Opioide used as analgesia and for opioid
dependence
0.94 0.11 1.4
Clonazepam Benzodiazepinec,e; anticonvulsant, anxiolytic 0.19 0 0
Cocaine Stimulantb 0.42 0.22 2.7
Codeine Opioid analgesice, antitussive 0.60 0.55 6.8
Diazepam Benzodiazepinee; anxiolytic, anticonvulsant,
sedative
0.11 1.2 4.1
Ethyl glucuronide (EtG) Metabolite of alcohol 5.7 0.3 4.1
Fenazepam Benzodiazepinec,e; anxiolytica 0.21 0 0
Fentanyl Opioid analgesice 0.20 0 0
Flunitrazepam Benzodiazepinee; anxiolytica 0.060 0 0
3,4-Methylenedioxy-methamphetamine
(MDMA)
Illegal psychedelic hallucinogenic drug 8.6 0 0
Methadone Opioide used mainly for opioid dependence,
but also for analgesia
3.5 0 0
Methamphetamine Stimulantb 1.7 0.11 1.4
Morphine Opioid analgesice, also metabolite of codeine
and heroin
1.3 0.22 2.7
Nitrazepam Benzodiazepinee; anxiolytic 0.17 0 0
Nordiazepam Metabolite of diazepame 0.11 1.1 14
Oxazepam Benzodiazepinee; anxiolytic, anticonvulsant,
and metabolite of diazepam
0.17 1.3 16
Oxycodone Opioid analgesice 2.1 0 0
Δ9-Tetrahydrocannabinol (THC) Cannabisc 0.63 0.11 1.4
Tramadol Opioid analgesice 8.8 0.11 1.4
Zolpidem Short acting z-hypnotice 0.43 0.33 4.1
Zopiclone Short acting z-hypnotice 0.54 4.0 50
Benzodiazepines 3.1 37.8
Illicit drugs 0.6 6.8
Opioids 1.0 12.2
Medicinal drugs 7.3 89.2
Z-hypnotics 4.4 54.1
Total positive of all workers 8.2 100
Note: aNot marketed in Norway, bIllegal in Norway, cMostly used illegally in Norway, dConcentrations in neat OF, eClassified as a medicinal drug.
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Statistical analyses were carried out using PASW® Statistics
(SPSS version 20) and Microsoft Excel 2010. Associationswere analyzed in bi-variate cross tables. Chi-square
statistics were used to assess statistical significance.
The level of statistical significance was set as p < 0.05.
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Participants
A total of 933 HPs were invited to participate, representing
hospital departments (n = 778) and hospital pharmacies
(n = 155) (Tables 2 and 3). A total of 916 employees
participated (participation rate 98.2%); 916 completed the
questionnaire, and 907 samples of OF were collected.
The study population consisted of HPs from 7 different
workplaces, and their background and education were quite
wide, giving a variety in this population. The distribution of
gender, age, workplace and educational level for the
participants was evenly distributed and is presented in
Tables 2 and 3. The exception from the even distribution
was, however, that nearly half of the participants from the
hospital pharmacies had education at the upper secondary
school level (49%), whereas the majority of the hospital
workers had college/academy/university education (82%).
Analysis of oral fluid
As presented in Table 1, 8.2% of the OF samples contained
at least one compound, and some of the compounds
analyzed for were not detected. EtG is a specific biomarker
of alcohol intake that can be analyzed in biological samples.
The prevalence was very low as shown in Table 1. Illicit
drugs were found in 0.6% of the samples. The mostTable 2 Sample characteristics and prevalence of positive ora
educational level
Proportion (%) Positive
sample (%)
Medicinal
drugs (%)b
Gendera (n = 899) NS NS
Men 18.9 7.1 6.5
Women 81.1 8.5 7.5
Age groupa (n = 903) NS NS
<30 15.1 6.7 6.7
30-39 27.1 4.5 4.1
40-49 27.1 9.1 7.9
50-59 22.4 10.9 9.5
60+ 8.3 13.3 12
Age 40a (n = 903) p = 0.006 p = 0.023
<40 42.2 5.3 5.1
40+ 57.8 10.4 9.1
Workplace (n = 933) p = 0.019 p = 0.018
Pharmacy 16.6 3.4 2.7
Hospital 83.4 9.1 8.2
Educational levela (n = 852) NS p = 0.014
Primary and secondary school 2.1 16.7 16.7
Upper secondary school 21.1 4.6 2.9
College/academy/university 76.8 9.2 8.5
aAge, gender and educational level were unknown for some participants.
bThe medicinal drugs includes opioids that may be prescribed.
NSno significant association.frequently detected illicit drug was cocaine (0.3%). No
employees below the age of forty tested positive for illicit
drugs in this study (Table 2). The prevalence of medicinal
drugs including opioids, benzodiazepines and z-hypnotics
is presented in Table 1. Z-hypnotics were most frequently
detected (4.3%). The second largest medicinal drug group
found was the benzodiazepines, which were found in 3.1%
of the samples. The opioids were the smallest group of
medicinal drugs that was detected. A total of 1% tested
positive for an opioid.
No significant gender differences were found in the
prevalence of medicinal drugs in OF, but it was
significantly higher among those aged above 40 years
(χ2 (1, N = 893) = 5.185, p = 0.023). Moreover, the preva-
lence of medicinal drug use was significantly higher
among employees in hospitals than among pharmacy
workers (χ2 (1, N = 907) = 5.572, p = 0.018). Finally,
medicinal drugs were more frequently used by those
with primary and secondary school as their highest
educational level than by those with a higher educational
level (χ2 (2, N = 842) = 8.525, p = 0.014).
Results from questionnaires
Some of the questionnaires were incompletely filled in.
Therefore gender, age group and educational level arel fluid samples by gender, age, workplace and
Illicit
drugs (%)
Benzodiazepines (%) Z-hypnotics (%) Opioids (%)
NS NS NS NS
0.6 4.8 3 1.8
0.6 2.6 4.9 0.8
NS NS p = 0.031 NS
0 4.5 1.5 1.5
0 1.7 2.5 0.4
1.2 2.5 5.8 1.2
0.5 5 5.5 0.5
1.3 2.7 9.3 2.7
p = 0.056 NS p = 0.004 NS
0 2.7 2.1 0.8
1 3.5 6.2 1.2
NS NS NS NS
0.7 0.7 2 0
0.5 3.6 4.9 1.2
NS NS NS NS
0 5.6 11.1 0
1.1 1.1 1.7 0
0.5 3.5 5.1 1.2
Table 3 Self-reported absence and in-efficiency at work due to alcohol use during the past 12 months, medicinal drug
use during the past 48 hours and illicit drug use during the past 12 months by gender, age, workplace and
educational level
Proportion (%) Absence due to
alcohol (%)
In-efficiency/Hangover
due to alcohol (%)
Medicinal drug use (%) Illicit drug use (%)
Gendera (n = 899) NS NS NS NS
Men 18.9 1.8 14.7 6.0 10.6
Women 81.1 0.7 11.8 4.4 6
Age groupa (n = 903) NS p < 0.001 p = 0.015 p < 0.001
<30 15.1 1.5 22.1 1.5 24.2
30-39 27.1 0.8 15.5 2.0 8.6
40-49 27.1 1.2 10.2 6.7 3.1
50-59 22.4 0.5 6.9 6.5 1.6
60+ 8.3 0 4.0 8.1 0
Age 40a (n = 903) NS p < 0.001 p = 0.001 p < 0.001
<40 42.2 1 17.8 1.9 13.6
40+ 57.8 0.8 8.0 6.8 2.1
Workplace (n = 933) NS NS p = 0.034 −
Pharmacy 16.6 1.9 12.3 1.3 0
Hospital 83.4 0.7 12.2 5.3 6.8
Educational levela (n = 852) NS p = 0.002 p = 0.028 NS
Primary and secondary school 2.1 0 5.6 16.7 0
Upper secondary school 21.1 0.6 5.0 2.8 5.9
College/academy/university 76.8 1.1 14.4 4.9 7.1
aAge, gender and educational level were unknown for some participants.
NSno significant association.
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questionnaire are presented in Table 3.
Thirteen per cent of the respondents had consumed
alcohol during the past 24 hours, and 5.7% of them
had consumed four or more drinks during the past
24 hours. About 1% of the respondents had been
absent from work due to drinking alcohol during the past
12 months, and 12.2% had experienced in-efficiency
or hangover at work due to alcohol use during the
past 12 months. Nearly 13% consumed six drinks or
more during one drinking session at least once a
month during the past 12 months. Finally, 9.1% of
the employees reported not drinking any alcohol during
the past 12 months.
The prevalence of reporting absence from work due
to drinking alcohol during past 12 months was fairly
similar across genders, age groups, the various work-
places and among persons with different educational
levels (Table 3). Self-reported in-efficiency or hangover at
work due to alcohol during the past 12 months was
significantly lower in the age group above 40 years
(χ2 (1, N = 903) = 19.780, p = 0.000) and significantly higher
with increasing educational level (χ2 (2, N = 852) = 12.331,
p = 0.002).No one reported having used illicit drugs during the past
48 hours, but nearly 2% reported having used illicit drugs
during the past 12 months. No one reported being absent
from work because of using such drugs during the past
12 months, and no one reported in-efficiency at work
because of illicit drug use during the past 12 months. The
prevalence of illicit drug use during the past 12 months
was significantly higher among young than among older
employees (χ2 (1, N = 248) = 12.524, p = 0.000) (Table 3).
Self-reported medicinal drug use during the past
48 hours was 4.6%, and 16.7% of these recent users
reported that they had been absent from work because
of using medicinal drugs the past 12 months. Moreover,
26.2% of the recent users reported in-efficiency at
work because of medicinal drug use the past 12 months.
The prevalence of medicinal drug use during the past
48 hours was significantly higher among employees
aged above 40 years than among younger employees
(χ2 (1, N = 892) = 11.931, p = 0.001), it was higher among
hospital workers than among pharmacy workers (χ2
(1, N = 905) = 4.504, p = 0.034) and it was higher
among respondents having primary and secondary school
as their highest education level than among those with a
higher level of education (χ2 (2, N = 843) = 7.158, p = 0.028).
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analytical results from OF, supplementary information
on the recent use of psychoactive substances may be
revealed. Detection of drugs in samples of OF indicates,
in general, drug use during the past 24–48 hours [23].
The prevalence of self-reported use of illicit drugs was
0%, but the prevalence of positive OF samples was 0.6%
suggesting under-reporting of illicit drug use. For
alcohol, a lower prevalence of EtG was found in OF than
self-reported consumption of four drinks or more the
past 24 hours (0.3% versus 0.8%). Under-reporting did
not seem to be significant for medicinal drugs either,
with a prevalence of 4.6% for self-reported use the past
48 hours versus 3.1% positive samples for medicinal
drugs. Under-reporting was less frequent in this study
than in the pilot study, suggesting that HPs under-report to
a smaller extent than other workers [11]. This information
may be useful for future studies.Discussion
This study represents the first attempt to estimate the
prevalence of alcohol and drug use and impairment
and absence due to such use among HPs in Norway
and whether such use depends on socio-demographic
attributes such as gender, age, educational level and
workplace.Prevalence of alcohol and drug use measured by
questionnaire and oral fluid analysis
The results from this study showed that this sample of
HPs seldom used illicit drugs, few had a high level of
alcohol consumption, and few tested positive for medicinal
drugs. Alcohol and illicit drug use was lower than found in
a previous pilot study of employees [11], which did
not include HPs. Our findings in OF samples and
from questionnaires suggest that the prevalence of
problems is less frequent among HPs in Norway than
in some other countries. In a survey conducted among
student nurses from the US, 11.5% reported past misuse
of medications [24]. A study conducted by Kenna and
Wood measured the prevalence of alcohol and illicit drug
use among dentists and some physicians, revealing a
higher prevalence than found in our study [25]. Marijuana
was used the past year by 8.8% of the dentists and 3.8% of
the physicians. In our study the prevalence was 1.9% for
use of all illicit drugs the past year in the sample as a
whole. THC has a relatively short detection time in OF
and that may be an explanation of why cannabis was not
the most frequently detected illicit drug in this study
[23,26]. Nevertheless, our findings correspond quite well
with the findings of Nesvåg and Lie, were 2.6% reported
use of cannabis and/or other illicit drugs once or more
during the past 12 months [13].Psychoactive drugs may cause several problems when
used or abused at work, especially if their effects are
sedating. Only 4.6% of the participants reported having
used such drugs within 48 hours, and most of the
use is probably therapeutically use of sleeping agents
and tranquilizers.
EtG was found in a very small proportion of the OF
samples. A previous study found that an intake of about
one bottle of wine gave a positive EtG up to 12 hours
after starting drinking [27]. Therefore, a large intake of
alcohol is needed to produce sufficient EtG for detection
in samples of OF the next day. The variation was large,
so the correlation between recent alcohol intake and
concentration of EtG in OF is fairly low [27]. This may
explain why we did not find more than three positive
samples for EtG even though seven respondents
reported drinking four or more drinks during the past
24 hours; only one of them had positive EtG. The two
other positive EtG samples were found in persons that
reported lower alcohol consumption the day before than
four or more drinks. The fact that we did not detect any
alcohol positive samples implies that none of the
respondents had a recent intake of alcohol exceeding
a blood alcohol concentration of 0.1 g/L or more at the
time of sample collection. Therefore, working under the
influence of alcohol did not seem to be a significant
problem among this group of HPs; neither was working
after a large alcohol intake the day before.
These results may suggest that HPs are more reluctant
to use alcohol or illicit drugs than employees in other
types of businesses. This assumption is supported by the
results from an American study, where employees in the
Healthcare and Social Assistance reported less past
month illicit drug use and past month heavy alcohol use
than most other industries [2].
The use of medicinal drugs was found to be higher,
at least partly because of differences in age and gender
between this study and the pilot study [11]. In this study,
more than 8/10 were women and the age distribution was
even, while in the pilot more than 2/3 were men and the
age was lower.
Self-reported absence from and impairment at work due
to alcohol and drug use
Self-reported data covering the past 12 months indicated
that hangover after alcohol use (12.2%) and absence
from work due to drinking alcohol (0.9%) was a larger
problem than impairment by alcohol (0%) or drugs at
work. Psychoactive drugs may cause several problems
when used or abused at work, especially if their effects
are sedating. Only 4.6% of the participants reported
having used such drugs within 48 hours, and most of the
use is probably therapeutically use of sleeping agents and
tranquilizers. However, 1/6 of these recent self-reported
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of use of medicinal drugs during the past 12 months,
and more than 1/4 of them reported in-efficiency at
work because of the use of medicinal drugs during
the past 12 months. The total prevalence of these negative
side effects of medicinal drug use was low in this study
population. Self-reported in-efficiency or hangover at
work due to alcohol and drug use was also significantly
less prevalent than found in the pilot study [11], which is
the most comparable study that has been performed with
both OF samples and questionnaires.Alcohol and drug use in relation to age, gender,
educational level and workplace
This study did not find any significant gender differences
regarding alcohol and drug use. As expected [4,28], the
younger employees had a higher alcohol consumption
than the older employees, but medicinal drug use was
more frequent among older employees than among
younger employees. Similar results have been reported
by Skretting et al., Gjerde et al. and Nesvåg and Lie
[13,15,16]. Self-reported in-efficiency or hangover at
work due to alcohol during the past 12 months was
more frequent among the age group below 40 years and
among employees with higher educational level, and
the results were consistent with data published by
Storvoll et al. [17]. Lower educational level and
working at a hospital rather than at a hospital pharmacy
was associated with more medicinal drug use in this study.Strengths/limitations
The strengths of this study were that the participating and
testing was done unannounced, that the participation rate
was close to 100%, and that all the samples were tested at
the same laboratory giving a high analytical reproducibility.
A large proportion of the employees (97%) provided
samples of OF. In addition, the participation was not
time consuming, taking only five minutes. The analytical
methods detected a wide range of psychoactive substances.
The study was anonymous. Finally, the study included HPs
with many different backgrounds, as described in the
methods section, providing a wide variety of HPs. One
limitation of this study was that a small proportion of the
participants did not give information concerning gender,
age group, or educational level. Moreover, the included
hospitals were of small to middle size, and hospitals
and pharmacies were located in the southern part of
the country only, and some sectors in the health care
business were not included (dentistry, primary health
care, private clinics, different public institutions, etc.).
Thus, in order to obtain more representative figures
of the prevalence of alcohol and drug use among HPs
in Norway, future studies would most likely benefitfrom including HPs from all parts of the country and
from a wider range of health care businesses.
Samples of OF only reflect a relatively short time
frame; it may be considered as a real-time test: if a drug
is detected in a sample of OF it is also likely to be
present in blood. Samples of OF have a detection
window varying from about 6 h to 48 h after use depending
on drug type and dose taken [29]. A long detection time
may confuse the interpretation of the results, with shorter
detection time, the risk of actually being under the
influence of alcohol and drugs is quite high with a
concomitant positive sample of OF. This study aimed at
trying to measure as recent drug intake as possible, rather
than drug intake that no longer has an influence on the
work-situation. However, a large intake or several intakes
over a few days of a slowly eliminated drug may be
detected for a longer time. It is unlikely that such use was
common among the drug positive employees.
Methodological considerations
None of the OF samples used in this study was collected
during the weekends, and approximately 70% of the
drinking situations in Norway take place during the
weekend [28], it is therefore not very surprising that the
prevalence of recent alcohol use, measured as alcohol
and EtG in OF, was fairly low in this study. It is also
known that illicit drug use is more frequent in the late
night during weekends [30]. For that reason, it is reasonable
to assume that most of the illicit drug use among this group
occurs during weekends (i.e., recreational drug use). When
it comes to use of medicinal drugs, they are probably
mostly used therapeutically and thus this use is likely to be
more evenly distributed through week days and gives a
higher prevalence than was the case for illicit drugs and
alcohol. Moreover, when using self-reported information it
is important to acknowledge the fact that under-reporting
is common [31,32] and it is reasonable to expect it to be
even more likely for information concerning illicit actions
such as illicit drug use as indicated by the findings of the
current study and the study by Gjerde et al. [11]. A final
issue to the methodological considerations is that when
analyzing OF, very low concentrations (i.e., below the ana-
lytical LLOQ) will not be considered as positive findings.
For benzodiazepines the concentrations in OF are mostly
much lower compared to blood samples [33]. Finally,
analytes that are not included in the analytical repertoire
will not be detected nor considered as positive. One major
drawback with the self-reported data is the ability to
under- and over-report, giving bias to the results. We
have tried to reduce this problem by using OF samples.
Conclusion
The total number of positive samples and self-reported
use of alcohol and drugs was low among this sample of
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alcohol use was lower than in other business sectors in
Norway and other countries. Even though intoxication
has been reported to be the most common cause of loss
of authorization to work in healthcare in Norway, being
unfit to work due to acute alcohol or drug intoxication
did not seem to be widespread in this group. Overall,
few participants reported use of illicit drugs, or having a
large consumption of alcohol. Most of the use of medicinal
drugs was probably therapeutically use of sleeping agents
and tranquilizers. The majority of samples found positive
for medicinal drugs were from participants above 40 years
old, working at a hospital rather than in a pharmacy, and
without education above secondary school. Nevertheless, it
should be emphasized that a relatively large fraction of the
HPs reported absence from work and reduced efficiency at
work due to alcohol and particularly medical drug use
during the past 12 months., i.e., impairment due to
medicinal drugs and alcohol use appeared to be a bigger
issue in the work setting than the effects of acute intoxica-
tion or the use of illicit drugs. However, the overall problem
was low-prevalent. This study did not include all health
care sectors from every part in Norway; therefore future
studies would most likely obtain more representative
measures of the prevalence of alcohol and drug use among
all HPs by including HPs from all parts of the country and
from a wider range of health care businesses.
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